SCHEMBL540857

SCHEMBL540857

CCCCCCNc1ncnc2sc3c(c12)CCCC3

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.64
CSNK2B P67870 1/20 0.64
CSNK2A1 P68400 1/20 0.64
RXFP1 Q9HBX9 1/20 0.61
MEN1 O00255 1/20 0.61
PTGS2 P35354 3/20 0.60
ALDH1A1 P00352 3/20 0.59
LMNA P02545 4/20 0.58
TSHR P16473 3/20 0.58
GAA P10253 2/20 0.58
MAPT P10636 3/20 0.58
PDE5A O76074 1/20 0.58
HTT P42858 2/20 0.56
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GFER P55789 1/20 0.56
KDM4E B2RXH2 1/20 0.55
REN P00797 1/20 0.55
MKNK1 Q9BUB5 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19523723 0.98 ALDH1A1 (0.62) CSNK2A2CSNK2BCSNK2A1RXFP1MEN1
SCHEMBL1604847 0.85 CSNK2A2 (0.67) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2
SCHEMBL13164925 0.84 CSNK2A2 (0.63) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2
SCHEMBL13164903 0.78 CSNK2A2 (1.00) CSNK2A2CSNK2BCSNK2A1RXFP1MEN1
SCHEMBL13164894 0.78 MAPT (0.84) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2
SCHEMBL10237224 0.77 MAPT (0.68) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2
SCHEMBL13164898 0.77 MEN1 (0.98) CSNK2A2CSNK2BCSNK2A1RXFP1MEN1
SCHEMBL759362 0.76 LMNA (0.63) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2
SCHEMBL14623890 0.76 CSNK2A2 (0.65) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2
SCHEMBL13164924 0.76 PDE5A (0.61) CSNK2A2CSNK2BCSNK2A1MEN1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2413696-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE Mount Sinai School Of Medicine Of New York University (US) 2012-02-08 EP claimed
WO-2010114636-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) 2010-10-07 WO claimed
EP-2413696-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE Mount Sinai School Of Medicine Of New York University (US) 2012-02-08 EP disclosed
WO-2010114636-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) 2010-10-07 WO disclosed
WO-2010114636-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) 2010-10-07 WO disclosed